首页> 外文期刊>Molecular pharmacology. >125I)2-(2-chloro-4-iodo-phenylamino)-5-methyl-pyrroline (LNP 911), a high-affinity radioligand selective for I1 imidazoline receptors.
【24h】

125I)2-(2-chloro-4-iodo-phenylamino)-5-methyl-pyrroline (LNP 911), a high-affinity radioligand selective for I1 imidazoline receptors.

机译:125I)2-(2-氯-4-碘-苯基氨基)-5-甲基吡咯啉(LNP 911),对I1咪唑啉受体具有选择性的高亲和力放射性配体。

获取原文
获取原文并翻译 | 示例
           

摘要

The I1 subtype of imidazoline receptors (I1R) is a plasma membrane protein that is involved in diverse physiological functions. Available radioligands used so far to characterize the I(1)R were able to bind with similar affinities to alpha2-adrenergic receptors (alpha2-ARs) and to I1R. This feature was a major drawback for an adequate characterization of this receptor subtype. New imidazoline analogs were therefore synthesized and the present study describes one of these compounds, 2-(2-chloro-4-iodo-phenylamino)-5-methyl-pyrroline (LNP 911), which was of high affinity and selectivity for the I1R. LNP 911 was radioiodinated and its binding properties characterized in different membrane preparations. Saturation experiments with [125I]LNP 911 revealed a single high affinity binding site in PC-12 cell membranes (K(D) = 1.4 nM; B(max) = 398 fmol/mg protein) with low nonspecific binding. [125I]LNP 911 specific binding was inhibited by various imidazolines and analogs but was insensitive to guanosine-5'-O-(3-thio)triphosphate. The rank order of potency of some competing ligands [LNP 911, PIC, rilmenidine, 4-chloro-2-(imidazolin-2-ylamino)-isoindoline (BDF 6143), lofexidine, and clonidine] was consistent with the definition of [125I]LNP 911 binding sites as I1R. However, other high-affinity I1R ligands (moxonidine, efaroxan, and benazoline) exhibited low affinities for these binding sites in standard binding assays. In contrast, when [125I]LNP 911 was preincubated at 4 degrees C, competition curves of moxonidine became biphasic. In this case, moxonidine exhibited similar high affinities on [125I]LNP 911 binding sites as on I1R defined with [125I]PIC. Moxonidine proved also able to accelerate the dissociation of [125I]LNP 911 from its binding sites. These results suggest the existence of an allosteric modulation at the level of the I1R, which seems to be corroborated by the dose-dependent enhancement by LNP 911 of the agonist effects on the adenylate cyclase pathway associated to I1R. Because [125I]LNP 911 was unable to bind to the I2 binding site and alpha2AR, our data indicate that [125I]LNP 911 is the first highly selective radioiodinated probe for I1R with a nanomolar affinity. This new tool should facilitate the molecular characterization of the I1 imidazoline receptor.
机译:咪唑啉受体的I1亚型(I1R)是质膜蛋白,参与多种生理功能。迄今为止,可用以表征I(1)R的可用放射性配体能够以相似的亲和力与α2-肾上腺素能受体(alpha2-ARs)和I1R结合。该特征是对该受体亚型进行充分表征的主要缺点。因此,合成了新的咪唑啉类似物,本研究描述了其中一种化合物2-(2-氯-4-碘-苯基氨基)-5-甲基-吡咯啉(LNP 911),它对I1R具有高亲和力和选择性。 。对LNP 911进行了放射性碘标记,并在不同的膜制剂中表征了其结合特性。用[125I] LNP 911进行的饱和实验揭示了PC-12细胞膜中的单个高亲和力结合位点(K(D)= 1.4 nM; B(max)= 398 fmol / mg蛋白),具有低非特异性结合。 [125I] LNP 911特异性结合被各种咪唑啉和类似物抑制,但对鸟苷5'-O-(3-硫代)三磷酸不敏感。某些竞争性配体[LNP 911,PIC,利美替尼,4-氯-2-(咪唑啉-2-基氨基)-异吲哚啉(BDF 6143),洛美替丁和可乐定]的效能等级顺序与[125I]的定义一致LNP 911结合位点为I1R。但是,在标准结合试验中,其他高亲和力的I1R配体(莫索尼定,依法沙星和苯并唑啉)对这些结合位点的亲和力较低。相反,将[125I] LNP 911在4摄氏度下预孵育时,莫索尼定的竞争曲线变为双相。在这种情况下,莫索尼定在[125I] LNP 911结合位点上显示出与[125I] PIC定义的I1R上相似的高亲和力。莫索尼定被证明还能够促进[125I] LNP 911从其结合位点解离。这些结果表明在I1R水平存在变构调节,这似乎被LNP 911对与I1R相关的腺苷酸环化酶途径的激动剂作用的剂量依赖性增强所证实。因为[125I] LNP 911无法结合到I2结合位点和alpha2AR,所以我们的数据表明[125I] LNP 911是第一个具有纳摩尔亲和力的I1R的高选择性放射性碘标记探针。这种新工具应有助于I1咪唑啉受体的分子表征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号